P79.09 Neoadjuvant Combination Sintilimab plus Chemotherapy in Patients with Resectable Stage IIIA Non-Small Cell Lung Cancer.

Category Primary study
JournalJournal of Thoracic Oncology
Year 2021
This article has no abstract
Epistemonikos ID: f3207c417ae8df289311de3589a4b210a6da24b8
First added on: Feb 12, 2025